Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents

Physica Medica

Volumn 23, Issue 3-4, 2007, Pages 85-90

  Ivanuša, Teodora ^a   Beravs, Katarina ^b   Medič, Jure ^a   Serša, Igor ^b   Serša, Gregor ^c   Jevtič, Vladimir ^a   Demsar, Franci ^b   Mikac, Urša ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Blood volume; Keyhole; Macromolecular contrast agent; Permeability

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE POLYLYSINE; GADOMER 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BLOOD VOLUME; CALCULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DATA ANALYSIS; DRUG ACCUMULATION; DRUG PENETRATION; FEMALE; FIBROSARCOMA; MACROMOLECULE; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR VASCULARIZATION;

ANIMALS; BLOOD VOLUME; CAPILLARY PERMEABILITY; CONTRAST MEDIA; DIFFUSION; ENDOTHELIAL CELLS; FIBROSARCOMA; GADOLINIUM; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MICE; POLYLYSINE;

ANIMALIA; MUS;

EID: 36448957148     PISSN: 11201797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmp.2007.05.001     Document Type: Article

References (28)

1. Brasch R.C., Weinmann H.J., and Wesbey G.E. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol 142 (1984) 625-630
2. Weinmann H.J., Laniado M., and Mutzel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16 (1984) 167-173
3. Shames D., Kuwatsuru R., Vexler V., Muehler A., and Brasch R. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique. Magn Reson Med 29 (1993) 616-622
4. Kuwutsuru R., Shames D., Muhler A., Mintorovich J., Vexler V., Mann J.S., et al. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 30 (1993) 76-81
5. Demsar F., Roberts T.P.L., Schwickert H.C., Shames D.M., Van Dijke C.F., Mann J.S., et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 37 (1997) 236-242
6. Gossmann A., Okuhata Y., Shames D.M., Helbich T.H., Roberts T.P.L., Wendland M.F., et al. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular contrast media-preliminary experience. Radiology 213 (1999) 265-272
7. Sato N., Kobayashi H., Hiraga A., Saga T., Togashi K., Konishi J., et al. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn Reson Med 46 (2001) 1169-1173
8. Graff B.A., Vangberg L., and Rofstad E.K. Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI. Magn Reson Med 51 (2004) 727-735
9. Preda A., van Vliet M., Krestin G.P., Brasch R.C., and van Dijke C.F. Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition. Invest Radiol 41 (2006) 325-331
10. 30 for microvessel characterization in an intracranial glioma model. J Magn Reson Imaging 8 (1998) 799-806
11. Van Vaals J.J., Brummer M.E., Dixon W.T., Tuithof H.H., Engels H., Nelson R.C., et al. "Keyhole" method for accelerating imaging of contrast agent uptake. J Magn Reson Imaging 3 (1993) 671-675
12. Spraggins T.A. Simulation of spatial and contrast distortions in keyhole imaging. Magn Reson Med 31 (1994) 320-322
13. Larsson H.B., Stubgaard M., Frederiksen J.L., Jensen M., Hensriksen O., and Paulson O.B. Quantification of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 16 (1990) 117-131
14. Patlak C., Blasberg R., and Fenstermacher J. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3 (1983) 1-7
15. Demsar F., Shames D.M., Roberts T.P.L., Stiskal M., Roberts H.C., and Brasch R.C. Kinetics of MRI contrast agents with size ranging between Gd-DTPA and albumin-Gd-DTPA: use of cascade-Gd-DTPA-25-polymer. Electro Magnetobiol 17 (1998) 283-297
16. Cotran P.S., Kumar V., and Robbins S.L. Inflammation and repair. In: Robbins S.L., and Kumar V. (Eds). Pathologic basis of diseases. 4th ed. vol. 2 (1989), Saunders, Philadelphia
17. Sage M.R. Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. AJR Am J Roentgenol 138 (1982) 887-898
18. Dvorak H., Brown L., Detman M., and Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
19. Catalona W. Surgical management of prostate cancer: contemporary results with anatomic radical prostatectomy. Cancer 75 (1995) 1903-1908
20. Jager G.J., Barentz J.O., Ruijter E.T.G., De la Rosette J.J.M.C.H., and Oosterhof G.O.N. Primary staging of prostate cancer. Eur Radiol 6 (1996) 134-139
21. Kucharczyk W., Bishop J.E., Plewes D.B., Keller M.A., and George S. Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging. AJR Am J Roengenol 163 (1994) 671-679
22. Serša I., Medič J., Beravs K., and Demsar F. Fast keyhole MR imaging using optimized k-space data acquisition. Electro Magnetobiol 17 (1998) 307-321
23. Medič J., Tomažič S., Serša I., and Demsar F. Contrast and resolution considerations in keyhole MRI: application to dynamic studies of contrast media kinetics. Electro Magnetobiol 17 (1998) 323-331
24. Bishop J.E., Santyr G.E., Kelcz F., and Plewes D.B. Limitations of the keyhole technique for quantitative dynamic contrast-enhanced breast MRI. J Magn Reson Imaging 7 (1997) 716-723
25. Huch Böni R.A., Boner J.A., Lütolf U.M., Trinkler F., Pestalozzi D.M., and Krestin G.P. Contrast enhanced endorectal coil MRI in local staging of prostate carcinoma. J Comput Assist Tomogr 19 (1995) 232-237
26. Mirowitz S.A., Brown J.J., and Heiken J.P. Evaluation of the prostate cancer and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. Radiology 186 (1993) 153-157
27. Sommer F.G., Nghiem H.V., Herfkens R., and McNeal J. Gadolinium-enhanced MRI of the abnormal prostate. Magn Reson Med 11 (1993) 941-948
28. Daldrup H., Shames D.M., Wendland M., Okuhata Y., Link T.M., Rosenau W., et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Am J Roentgenol 171 (1998) 941-949